glp-1 approved for type 1 diabetes GLP-1s Diabetes? What the First Expert Guidelines Say GLP-1-based therapies for diabetes, obesity

Unidentified fibrosis can evolve into more severe consequences over a period of time such as cirrhosis and hepatocellular carcinoma

2014: Dulaglutide (Trulicity) is approved by the FDA, and is recognized as the first type 2 diabetes drug to reduce the risk of major adverse cardiovascular events (MACE)

This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 50 print issues and online access 269,00 per year only 5,38 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

It serves vital functions at the cellular level, such as energy production

DSIP injections have been shown to improve motor control, skeletal muscle growth, and even blood pressure regulation, supporting overall well-being